MKI67 and neoplasm: Immunohistological analyses of tumor demonstrated a reduction in tumor angiogenesis (CD34), in proliferative activity (KI-67) and an increase in apoptosis (tunnel) in tumors treated with N6L compared with control tumors (Figure 5).